Sign inJoin waitlistJoin the waitlist

Erin Schenk

Associate Professor of Medicine, Division of Medical Oncology · University of Colorado

Credentials: · · · ·

History

University of Colorado
Present

College of Medicine, Mayo Clinic (Rochester) Program
Until 2018
College of Medicine, Mayo Clinic Program
Until 2014
Mayo Medical School
2011

Research

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
Cell · 2020 · 568 citations
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma
The Journal of Immunology · 2020 · 113 citations
Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
Review · Frontiers in Immunology · 2019 · 104 citations

Tejas Patil
11 papers · 2 as a fellow
Ross Camidge
10 papers
Narjust Florez
9 papers
JP
Jose Pacheco
8 papers
Paul Bunn
8 papers
Dwight Owen
7 papers
Lecia Sequist
7 papers
Dara Aisner
6 papers
JN
Jarushka Naidoo
6 papers
Lyudmila Bazhenova
6 papers
Balazs Halmos
5 papers
Bryan Schneider
5 papers

Grants

Tumor Microenvironment Determinants of TKI Response in Oncogene-Driven Lung Cancer
National Cancer Institute · K08
Contact PI · $838.4K · University of Colorado Denver
2024–2029

Clinical trials

Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET Alterations
Principal investigator · Active not recruiting · Phase 1, Phase 2
University of Colorado, Denver
2023–2028
Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.
Principal investigator · Recruiting
University of Colorado, Denver
2020–2028
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
Principal investigator · Recruiting
University of Colorado, Denver
2016–2027
Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
Principal investigator · Recruiting
University of Colorado, Denver
2012–2029